{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:49:46Z","timestamp":1778676586208,"version":"3.51.4"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021ZD0202402, 2021YFA1101401"],"award-info":[{"award-number":["2021ZD0202402, 2021YFA1101401"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82325018, U21A20358"],"award-info":[{"award-number":["82325018, U21A20358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Fujian Province of China","award":["2021J02004"],"award-info":[{"award-number":["2021J02004"]}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1515120081"],"award-info":[{"award-number":["2021B1515120081"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Fundamental Research Funds for the Chinese Central Universities","award":["20720230070"],"award-info":[{"award-number":["20720230070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-024-01722-w","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:26:13Z","timestamp":1721888773000},"page":"2575-2592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Role of Protein Quantity Control in Polyglutamine Spinocerebellar Ataxias"],"prefix":"10.1007","volume":"23","author":[{"given":"Hongfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"1722_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","volume":"104","author":"U R\u00fcb","year":"2013","unstructured":"R\u00fcb U, et al. Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol. 2013;104:38\u201366.","journal-title":"Prog Neurobiol"},{"issue":"10","key":"1722_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrn.2017.92","volume":"18","author":"HL Paulson","year":"2017","unstructured":"Paulson HL, et al. Polyglutamine spinocerebellar ataxias \u2014 from genes to potential treatments. Nat Rev Neurosci. 2017;18(10):613\u201326.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1722_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","volume":"124","author":"K Seidel","year":"2012","unstructured":"Seidel K, et al. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124(1):1\u201321.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1722_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S1474-4422(16)00099-5","volume":"15","author":"HH Kampinga","year":"2016","unstructured":"Kampinga HH, Bergink S. Heat shock proteins as potential targets for protective strategies in neurodegeneration. Lancet Neurol. 2016;15(7):748\u201359.","journal-title":"Lancet Neurol"},{"key":"1722_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","volume":"70","author":"CM Pickart","year":"2001","unstructured":"Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503\u201333.","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"1722_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/502","volume":"19","author":"CJ Cummings","year":"1998","unstructured":"Cummings CJ, et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet. 1998;19(2):148\u201354.","journal-title":"Nat Genet"},{"issue":"23","key":"1722_CR7","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1523\/JNEUROSCI.19-23-10338.1999","volume":"19","author":"Y Chai","year":"1999","unstructured":"Chai Y, et al. Analysis of the role of heat shock protein (hsp) molecular chaperones in polyglutamine disease. J Neurosci. 1999;19(23):10338\u201347.","journal-title":"J Neurosci"},{"issue":"2","key":"1722_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0014-5793(03)00605-7","volume":"546","author":"F-C Wen","year":"2003","unstructured":"Wen F-C, et al. Down-regulation of heat shock protein 27 in neuronal cells and non-neuronal cells expressing mutant ataxin-3. FEBS Lett. 2003;546(2):307\u201314.","journal-title":"FEBS Lett"},{"issue":"4","key":"1722_CR9","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.bbrc.2005.06.207","volume":"334","author":"H-F Tsai","year":"2005","unstructured":"Tsai H-F, et al. Decreased expression of Hsp27 and Hsp70 in transformed lymphoblastoid cells from patients with spinocerebellar ataxia type 7. Biochem Biophys Res Commun. 2005;334(4):1279\u201386.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1722_CR10","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1007\/s12035-016-0120-z","volume":"54","author":"SD Reis","year":"2017","unstructured":"Reis SD, Pinho BR, Oliveira JMA. Modulation of Molecular chaperones in Huntington\u2019s Disease and other Polyglutamine disorders. Mol Neurobiol. 2017;54(8):5829\u201354.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1722_CR11","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1038\/s41467-020-17145-0","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang S, et al. The ataxin-1 interactome reveals direct connection with multiple disrupted nuclear transport pathways. Nat Commun. 2020;11(1):3343.","journal-title":"Nat Commun"},{"issue":"6654","key":"1722_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/40153","volume":"389","author":"PJ Skinner","year":"1997","unstructured":"Skinner PJ, et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 1997;389(6654):971\u20134.","journal-title":"Nature"},{"issue":"3","key":"1722_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ana.10101","volume":"51","author":"T Schmidt","year":"2002","unstructured":"Schmidt T, et al. Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Annals Neurology: Official J Am Neurol Association Child Neurol Soc. 2002;51(3):302\u201310.","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"issue":"4","key":"1722_CR14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s13311-019-00778-5","volume":"16","author":"A Niewiadomska-Cimicka","year":"2019","unstructured":"Niewiadomska-Cimicka A, Trottier Y. Molecular targets and therapeutic strategies in spinocerebellar ataxia type 7. Neurotherapeutics. 2019;16(4):1074\u201396.","journal-title":"Neurotherapeutics"},{"issue":"3","key":"1722_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0969-9961(03)00080-9","volume":"13","author":"J Takahashi","year":"2003","unstructured":"Takahashi J, et al. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases. Neurobiol Dis. 2003;13(3):230\u20137.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"1722_CR16","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/brain\/124.10.1939","volume":"124","author":"H Fujigasaki","year":"2001","unstructured":"Fujigasaki H, et al. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain. 2001;124(10):1939\u201347.","journal-title":"Brain"},{"issue":"3","key":"1722_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.molcel.2004.12.021","volume":"17","author":"EJ Bennett","year":"2005","unstructured":"Bennett EJ, et al. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell. 2005;17(3):351\u201365.","journal-title":"Mol Cell"},{"issue":"1","key":"1722_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1016-8478(23)13132-3","volume":"19","author":"Y Park","year":"2005","unstructured":"Park Y, et al. Proteasome function is inhibited by polyglutamine-expanded Ataxin-1, the SCA1 gene product. Mol Cells. 2005;19(1):23\u201330.","journal-title":"Mol Cells"},{"issue":"7312","key":"1722_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature09299","volume":"467","author":"B-H Lee","year":"2010","unstructured":"Lee B-H, et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature. 2010;467(7312):179\u201384.","journal-title":"Nature"},{"key":"1722_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.01.006","volume":"70","author":"H-L Wang","year":"2013","unstructured":"Wang H-L, et al. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse. Neuropharmacology. 2013;70:1\u201311.","journal-title":"Neuropharmacology"},{"issue":"15","key":"1722_CR21","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1016\/j.febslet.2005.04.048","volume":"579","author":"MH Glickman","year":"2005","unstructured":"Glickman MH, Raveh D. Proteasome plasticity. FEBS Lett. 2005;579(15):3214\u201323.","journal-title":"FEBS Lett"},{"issue":"32","key":"1722_CR22","doi-asserted-by":"publisher","first-page":"22123","DOI":"10.1074\/jbc.274.32.22123","volume":"274","author":"GN DeMartino","year":"1999","unstructured":"DeMartino GN, Slaughter CA. The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem. 1999;274(32):22123\u20136.","journal-title":"J Biol Chem"},{"issue":"7356","key":"1722_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature10317","volume":"475","author":"FU Hartl","year":"2011","unstructured":"Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature. 2011;475(7356):324\u201332.","journal-title":"Nature"},{"key":"1722_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-12-397863-9.00004-3","volume":"109","author":"M K\u00e4stle","year":"2012","unstructured":"K\u00e4stle M, Grune T. Interactions of the proteasomal system with chaperones: protein triage and protein quality control. Prog Mol Biol Transl Sci. 2012;109:113\u201360.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"8","key":"1722_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nrm2938","volume":"11","author":"M \u00c5kerfelt","year":"2010","unstructured":"\u00c5kerfelt M, Morimoto RI, Sistonen L. Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol. 2010;11(8):545\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"1722_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0092-8674(00)81588-3","volume":"94","author":"J Zou","year":"1998","unstructured":"Zou J, et al. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell. 1998;94(4):471\u201380.","journal-title":"Cell"},{"key":"1722_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12035-010-8116-6","volume":"42","author":"TZ Lu","year":"2010","unstructured":"Lu TZ, Quan Y, Feng Z-P. Multifaceted role of heat shock protein 70 in neurons. Mol Neurobiol. 2010;42:114\u201323.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"1722_CR28","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/emboj\/16.7.1501","volume":"16","author":"S R\u00fcdiger","year":"1997","unstructured":"R\u00fcdiger S, et al. Substrate specificity of the DnaK chaperone determined by screening cellulose-bound peptide libraries. Embo j. 1997;16(7):1501\u20137.","journal-title":"Embo j"},{"issue":"10","key":"1722_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrm3658","volume":"14","author":"H Saibil","year":"2013","unstructured":"Saibil H. Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol. 2013;14(10):630\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"1722_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tibs.2008.12.009","volume":"34","author":"DW Summers","year":"2009","unstructured":"Summers DW, et al. Polypeptide transfer from Hsp40 to Hsp70 molecular chaperones. Trends Biochem Sci. 2009;34(5):230\u20133.","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"1722_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.neuroscience.2008.01.058","volume":"153","author":"S Quraishe","year":"2008","unstructured":"Quraishe S, et al. Expression of the small heat shock protein family in the mouse CNS: differential anatomical and biochemical compartmentalization. Neuroscience. 2008;153(2):483\u201391.","journal-title":"Neuroscience"},{"key":"1722_CR32","doi-asserted-by":"publisher","first-page":"462446","DOI":"10.3389\/fphar.2019.01047","volume":"10","author":"JM Webster","year":"2019","unstructured":"Webster JM, et al. Small heat shock proteins, big impact on protein aggregation in neurodegenerative disease. Front Pharmacol. 2019;10:462446.","journal-title":"Front Pharmacol"},{"issue":"11","key":"1722_CR33","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","volume":"14","author":"H Jacobi","year":"2015","unstructured":"Jacobi H, et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol. 2015;14(11):1101\u20138.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1722_CR34","first-page":"5765","volume":"7","author":"J Ma","year":"2014","unstructured":"Ma J, et al. Cognitive impairments in patients with spinocerebellar ataxia types 1, 2 and 3 are positively correlated to the clinical severity of ataxia symptoms. Int J Clin Exp Med. 2014;7(12):5765\u201371.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"1722_CR35","doi-asserted-by":"publisher","first-page":"dmm032623","DOI":"10.1242\/dmm.032623","volume":"11","author":"JP Orengo","year":"2018","unstructured":"Orengo JP, et al. Motor neuron degeneration correlates with respiratory dysfunction in SCA1. Dis Models Mech. 2018;11(2):dmm032623.","journal-title":"Dis Models Mech"},{"issue":"4","key":"1722_CR36","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s13311-019-00763-y","volume":"16","author":"SR Srinivasan","year":"2019","unstructured":"Srinivasan SR, Shakkottai VG. Moving towards therapy in SCA1: insights from molecular mechanisms, identification of novel targets, and planning for human trials. Neurotherapeutics. 2019;16(4):999\u20131008.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"1722_CR37","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1172\/JCI96765","volume":"128","author":"CR Edamakanti","year":"2018","unstructured":"Edamakanti CR, et al. Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1. J Clin Invest. 2018;128(6):2252\u201365.","journal-title":"J Clin Invest"},{"issue":"16","key":"1722_CR38","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.neuron.2023.05.016","volume":"111","author":"F Pilotto","year":"2023","unstructured":"Pilotto F, et al. Early molecular layer interneuron hyperactivity triggers Purkinje neuron degeneration in SCA1. Neuron. 2023;111(16):2523\u2013e254310.","journal-title":"Neuron"},{"issue":"1","key":"1722_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(00)81781-X","volume":"95","author":"IA Klement","year":"1998","unstructured":"Klement IA, et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 1998;95(1):41\u201353.","journal-title":"Cell"},{"issue":"1","key":"1722_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/hmg\/10.1.25","volume":"10","author":"S Yue","year":"2001","unstructured":"Yue S, et al. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. Hum Mol Genet. 2001;10(1):25\u201330.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"1722_CR41","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.cell.2015.02.012","volume":"160","author":"VA Gennarino","year":"2015","unstructured":"Gennarino VA, et al. Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels. Cell. 2015;160(6):1087\u201398.","journal-title":"Cell"},{"issue":"7188","key":"1722_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nature06731","volume":"452","author":"J Lim","year":"2008","unstructured":"Lim J, et al. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature. 2008;452(7188):713\u20138.","journal-title":"Nature"},{"issue":"5","key":"1722_CR43","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0896-6273(02)00697-9","volume":"34","author":"H Okazawa","year":"2002","unstructured":"Okazawa H, et al. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron. 2002;34(5):701\u201313.","journal-title":"Neuron"},{"issue":"4","key":"1722_CR44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuron.2022.11.016","volume":"111","author":"SL Coffin","year":"2023","unstructured":"Coffin SL, et al. Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1. Neuron. 2023;111(4):481\u2013e4928.","journal-title":"Neuron"},{"issue":"14","key":"1722_CR45","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1523\/JNEUROSCI.18-14-05508.1998","volume":"18","author":"A Matilla","year":"1998","unstructured":"Matilla A, et al. Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J Neurosci. 1998;18(14):5508\u201316.","journal-title":"J Neurosci"},{"issue":"7","key":"1722_CR46","doi-asserted-by":"publisher","first-page":"e1001021","DOI":"10.1371\/journal.pgen.1001021","volume":"6","author":"J Crespo-Barreto","year":"2010","unstructured":"Crespo-Barreto J, et al. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet. 2010;6(7):e1001021.","journal-title":"PLoS Genet"},{"issue":"4","key":"1722_CR47","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.neuron.2022.11.017","volume":"111","author":"HP Handler","year":"2023","unstructured":"Handler HP, et al. Decreasing mutant ATXN1 nuclear localization improves a spectrum of SCA1-like phenotypes and brain region transcriptomic profiles. Neuron. 2023;111(4):493\u2013507. e6.","journal-title":"Neuron"},{"issue":"3","key":"1722_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0896-6273(03)00258-7","volume":"38","author":"ES Emamian","year":"2003","unstructured":"Emamian ES, et al. Serine 776 of Ataxin-1 is critical for Polyglutamine-Induced Disease in SCA1 Transgenic mice. Neuron. 2003;38(3):375\u201387.","journal-title":"Neuron"},{"issue":"6","key":"1722_CR49","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.neuron.2010.08.022","volume":"67","author":"L Duvick","year":"2010","unstructured":"Duvick L, et al. SCA1-like Disease in mice expressing wild-type Ataxin-1 with a serine to Aspartic Acid replacement at Residue 776. Neuron. 2010;67(6):929\u201335.","journal-title":"Neuron"},{"key":"1722_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nbd.2018.05.002","volume":"116","author":"JM P\u00e9rez Ortiz","year":"2018","unstructured":"P\u00e9rez Ortiz JM, et al. Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model. Neurobiol Dis. 2018;116:93\u2013105.","journal-title":"Neurobiol Dis"},{"issue":"6808","key":"1722_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/35040584","volume":"408","author":"P Fernandez-Funez","year":"2000","unstructured":"Fernandez-Funez P, et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 2000;408(6808):101\u20136.","journal-title":"Nature"},{"issue":"5459","key":"1722_CR52","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1126\/science.287.5459.1837","volume":"287","author":"P Kazemi-Esfarjani","year":"2000","unstructured":"Kazemi-Esfarjani P, Benzer S. Genetic suppression of polyglutamine toxicity in <\u2009i\u2009>\u2009Drosophila. Science. 2000;287(5459):1837\u201340.","journal-title":"Science"},{"issue":"4","key":"1722_CR53","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/70532","volume":"23","author":"JM Warrick","year":"1999","unstructured":"Warrick JM, et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet. 1999;23(4):425\u20138.","journal-title":"Nat Genet"},{"issue":"19","key":"1722_CR54","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/hmg\/9.19.2811","volume":"9","author":"HYE Chan","year":"2000","unstructured":"Chan HYE, et al. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum Mol Genet. 2000;9(19):2811\u201320.","journal-title":"Hum Mol Genet"},{"issue":"14","key":"1722_CR55","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/hmg\/10.14.1511","volume":"10","author":"CJ Cummings","year":"2001","unstructured":"Cummings CJ, et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet. 2001;10(14):1511\u20138.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1722_CR56","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.bbrc.2009.12.018","volume":"391","author":"DH Lee","year":"2010","unstructured":"Lee DH, Goldberg AL. Hsp104 is essential for the selective degradation in yeast of polyglutamine expanded ataxin-1 but not most misfolded proteins generally. Biochem Biophys Res Commun. 2010;391(1):1056\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"1722_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-319-11731-7_11","volume":"78","author":"AL Edkins","year":"2015","unstructured":"Edkins AL. CHIP: a co-chaperone for degradation by the proteasome. Subcell Biochem. 2015;78:219\u201342.","journal-title":"Subcell Biochem"},{"issue":"36","key":"1722_CR58","doi-asserted-by":"publisher","first-page":"26714","DOI":"10.1074\/jbc.M601603200","volume":"281","author":"I Al-Ramahi","year":"2006","unstructured":"Al-Ramahi I, et al. CHIP protects from the neurotoxicity of expanded and wild-type Ataxin-1 and promotes their ubiquitination and Degradation*. J Biol Chem. 2006;281(36):26714\u201324.","journal-title":"J Biol Chem"},{"issue":"1","key":"1722_CR59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mcn.2006.10.002","volume":"34","author":"JY Choi","year":"2007","unstructured":"Choi JY, et al. Co-chaperone CHIP promotes aggregation of ataxin-1. Mol Cell Neurosci. 2007;34(1):69\u201379.","journal-title":"Mol Cell Neurosci"},{"issue":"9","key":"1722_CR60","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/hmg\/ddp067","volume":"18","author":"DA Parfitt","year":"2009","unstructured":"Parfitt DA, et al. The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. Hum Mol Genet. 2009;18(9):1556\u201365.","journal-title":"Hum Mol Genet"},{"key":"1722_CR61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuroscience.2016.03.064","volume":"327","author":"Y Ding","year":"2016","unstructured":"Ding Y, et al. BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1. Neuroscience. 2016;327:20\u201331.","journal-title":"Neuroscience"},{"issue":"4","key":"1722_CR62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0896-6273(00)81035-1","volume":"24","author":"CJ Cummings","year":"1999","unstructured":"Cummings CJ, et al. Mutation of the E6-AP Ubiquitin Ligase reduces nuclear inclusion frequency while accelerating Polyglutamine-Induced Pathology in SCA1 mice. Neuron. 1999;24(4):879\u201392.","journal-title":"Neuron"},{"issue":"10","key":"1722_CR63","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ncb859","volume":"4","author":"DL Stenoien","year":"2002","unstructured":"Stenoien DL, Mielke M, Mancini MA. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat Cell Biol. 2002;4(10):806\u201310.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"1722_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2008.05.125","volume":"372","author":"S Lee","year":"2008","unstructured":"Lee S, Hong S, Kang S. The ubiquitin-conjugating enzyme UbcH6 regulates the transcriptional repression activity of the SCA1 gene product ataxin-1. Biochem Biophys Res Commun. 2008;372(4):735\u201340.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1722_CR65","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbapap.2015.01.012","volume":"1854","author":"Ar Kang","year":"2015","unstructured":"Kang Ar, et al. A key lysine residue in the AXH domain of ataxin-1 is essential for its ubiquitylation. Biochim et Biophys Acta (BBA) - Proteins Proteom. 2015;1854(5):356\u201364.","journal-title":"Biochim et Biophys Acta (BBA) - Proteins Proteom"},{"issue":"40","key":"1722_CR66","doi-asserted-by":"publisher","first-page":"42290","DOI":"10.1074\/jbc.M406284200","volume":"279","author":"BE Riley","year":"2004","unstructured":"Riley BE, et al. The effects of the polyglutamine repeat protein ataxin-1 on the UbL-UBA protein A1Up. J Biol Chem. 2004;279(40):42290\u2013301.","journal-title":"J Biol Chem"},{"issue":"2","key":"1722_CR67","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1006\/mcne.2002.1103","volume":"20","author":"S Hong","year":"2002","unstructured":"Hong S, et al. USP7, a ubiquitin-specific protease, interacts with Ataxin-1, the SCA1 gene product. Mol Cell Neurosci. 2002;20(2):298\u2013306.","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"1722_CR68","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbrc.2010.01.122","volume":"393","author":"J Ryu","year":"2010","unstructured":"Ryu J, et al. Oxidative stress-enhanced SUMOylation and aggregation of ataxin-1: implication of JNK pathway. Biochem Biophys Res Commun. 2010;393(2):280\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"1722_CR69","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/hmg\/ddl173","volume":"15","author":"TF Satterfield","year":"2006","unstructured":"Satterfield TF, Pallanck LJ. Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. Hum Mol Genet. 2006;15(16):2523\u201332.","journal-title":"Hum Mol Genet"},{"key":"1722_CR70","doi-asserted-by":"crossref","unstructured":"Ostrowski LA, Hall AC, Mekhail K. Ataxin-2: from RNA Control to Human Health and Disease. Genes (Basel), 2017. 8(6).","DOI":"10.3390\/genes8060157"},{"issue":"7310","key":"1722_CR71","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466(7310):1069\u201375.","journal-title":"Nature"},{"issue":"1","key":"1722_CR72","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1038\/s41467-023-42147-z","volume":"14","author":"C Zeballos","year":"2023","unstructured":"Zeballos C. Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins. Nat Commun. 2023;14(1):6492.","journal-title":"Nat Commun"},{"issue":"7650","key":"1722_CR73","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker LA, et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 2017;544(7650):367\u201371.","journal-title":"Nature"},{"issue":"4","key":"1722_CR74","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s13311-019-00777-6","volume":"16","author":"PA Egorova","year":"2019","unstructured":"Egorova PA, Bezprozvanny IB. Molecular mechanisms and therapeutics for spinocerebellar ataxia type 2. Neurotherapeutics. 2019;16(4):1050\u201373.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"1722_CR75","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ajmg.a.20428","volume":"124","author":"P Moretti","year":"2004","unstructured":"Moretti P, et al. Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy. Am J Med Genet Part A. 2004;124(4):392\u20136.","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"1722_CR76","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/79162","volume":"26","author":"DP Huynh","year":"2000","unstructured":"Huynh DP, et al. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet. 2000;26(1):44\u201350.","journal-title":"Nat Genet"},{"key":"1722_CR77","doi-asserted-by":"crossref","unstructured":"Scoles DR et al. A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2. J Biol Chem, 2022. 298(8).","DOI":"10.1016\/j.jbc.2022.102228"},{"issue":"2","key":"1722_CR78","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.expneurol.2006.09.009","volume":"203","author":"DP Huynh","year":"2007","unstructured":"Huynh DP, et al. Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death. Exp Neurol. 2007;203(2):531\u201341.","journal-title":"Exp Neurol"},{"issue":"3","key":"1722_CR79","doi-asserted-by":"publisher","first-page":"e0121089","DOI":"10.1371\/journal.pone.0121089","volume":"10","author":"MV Halbach","year":"2015","unstructured":"Halbach MV, et al. Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated. PLoS ONE. 2015;10(3):e0121089.","journal-title":"PLoS ONE"},{"key":"1722_CR80","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/B978-0-444-51892-7.00027-9","volume":"103","author":"H Paulson","year":"2012","unstructured":"Paulson H. Machado\u2013Joseph disease\/spinocerebellar ataxia type 3. Handb Clin Neurol. 2012;103:437\u201349.","journal-title":"Handb Clin Neurol"},{"key":"1722_CR81","doi-asserted-by":"publisher","first-page":"104635","DOI":"10.1016\/j.nbd.2019.104635","volume":"134","author":"HS McLoughlin","year":"2020","unstructured":"McLoughlin HS, Moore LR, Paulson HL. Pathogenesis of SCA3 and implications for other polyglutamine diseases. Neurobiol Dis. 2020;134:104635.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1722_CR82","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","volume":"97","author":"MdC Costa","year":"2012","unstructured":"Costa MdC, Paulson HL. Toward understanding Machado\u2013Joseph disease. Prog Neurobiol. 2012;97(2):239\u201357.","journal-title":"Prog Neurobiol"},{"issue":"28","key":"1722_CR83","doi-asserted-by":"publisher","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","volume":"27","author":"U Bichelmeier","year":"2007","unstructured":"Bichelmeier U, et al. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J Neurosci. 2007;27(28):7418\u201328.","journal-title":"J Neurosci"},{"key":"1722_CR84","doi-asserted-by":"publisher","first-page":"105311","DOI":"10.1016\/j.nbd.2021.105311","volume":"153","author":"G Coarelli","year":"2021","unstructured":"Coarelli G, et al. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia. Neurobiol Dis. 2021;153:105311.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"1722_CR85","doi-asserted-by":"publisher","first-page":"e11803","DOI":"10.15252\/emmm.201911803","volume":"12","author":"C Wilke","year":"2020","unstructured":"Wilke C, et al. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice. EMBO Mol Med. 2020;12(7):e11803.","journal-title":"EMBO Mol Med"},{"key":"1722_CR86","doi-asserted-by":"crossref","unstructured":"Prudencio M et al. Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3. Sci Transl Med, 2020. 12(566).","DOI":"10.1126\/scitranslmed.abb7086"},{"issue":"11","key":"1722_CR87","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/mds.28749","volume":"36","author":"J H\u00fcbener-Schmid","year":"2021","unstructured":"H\u00fcbener-Schmid J, et al. Polyglutamine-expanded Ataxin-3: a Target Engagement marker for Spinocerebellar Ataxia Type 3 in peripheral blood. Mov Disord. 2021;36(11):2675\u201381.","journal-title":"Mov Disord"},{"key":"1722_CR88","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2021.07.018","volume":"89","author":"Y Koike","year":"2021","unstructured":"Koike Y, et al. Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2021;89:151\u20134.","journal-title":"Parkinsonism Relat Disord"},{"key":"1722_CR89","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pneurobio.2015.06.004","volume":"132","author":"X Li","year":"2015","unstructured":"Li X, et al. Toward therapeutic targets for SCA3: insight into the role of Machado\u2013Joseph disease protein ataxin-3 in misfolded proteins clearance. Prog Neurobiol. 2015;132:34\u201358.","journal-title":"Prog Neurobiol"},{"issue":"5","key":"1722_CR90","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1460-9568.2010.07352.x","volume":"32","author":"M Zijlstra","year":"2010","unstructured":"Zijlstra M, et al. Levels of DNAJB family members (HSP40) correlate with disease onset in patients with spinocerebellar ataxia type 3. Eur J Neurosci. 2010;32(5):760\u201370.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"1722_CR91","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.molcel.2020.02.022","volume":"78","author":"A Thiruvalluvan","year":"2020","unstructured":"Thiruvalluvan A, et al. DNAJB6, a key factor in neuronal sensitivity to amyloidogenesis. Mol Cell. 2020;78(2):346\u201358. e9.","journal-title":"Mol Cell"},{"issue":"3","key":"1722_CR92","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2010.01.001","volume":"37","author":"J Hageman","year":"2010","unstructured":"Hageman J, et al. A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation. Mol Cell. 2010;37(3):355\u201369.","journal-title":"Mol Cell"},{"issue":"2","key":"1722_CR93","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12192-013-0448-5","volume":"19","author":"C M\u00e5nsson","year":"2014","unstructured":"M\u00e5nsson C, et al. DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios. Cell Stress Chaperones. 2014;19(2):227\u201339.","journal-title":"Cell Stress Chaperones"},{"issue":"24","key":"1722_CR94","doi-asserted-by":"publisher","first-page":"17225","DOI":"10.1074\/jbc.M112.421685","volume":"288","author":"J Gillis","year":"2013","unstructured":"Gillis J, et al. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine Peptides*. J Biol Chem. 2013;288(24):17225\u201337.","journal-title":"J Biol Chem"},{"issue":"2","key":"1722_CR95","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.molcel.2016.03.017","volume":"62","author":"V Kakkar","year":"2016","unstructured":"Kakkar V, et al. The S\/T-rich motif in the DNAJB6 chaperone delays polyglutamine aggregation and the onset of disease in a mouse model. Mol Cell. 2016;62(2):272\u201383.","journal-title":"Mol Cell"},{"issue":"4","key":"1722_CR96","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.bbrc.2016.03.152","volume":"474","author":"N Ito","year":"2016","unstructured":"Ito N, et al. A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain independent manner. Biochem Biophys Res Commun. 2016;474(4):626\u201333.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1722_CR97","doi-asserted-by":"publisher","first-page":"e19763","DOI":"10.1371\/journal.pone.0019763","volume":"6","author":"XC Gao","year":"2011","unstructured":"Gao XC, et al. Co-chaperone HSJ1a dually regulates the proteasomal degradation of ataxin-3. PLoS ONE. 2011;6(5):e19763.","journal-title":"PLoS ONE"},{"issue":"1","key":"1722_CR98","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbrc.2005.08.065","volume":"336","author":"W-H Chang","year":"2005","unstructured":"Chang W-H, et al. Dynamic expression of Hsp27 in the presence of mutant ataxin-3. Biochem Biophys Res Commun. 2005;336(1):258\u201367.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"1722_CR99","doi-asserted-by":"publisher","first-page":"11635","DOI":"10.1074\/jbc.M412042200","volume":"280","author":"NR Jana","year":"2005","unstructured":"Jana NR, et al. Co-chaperone CHIP Associates with expanded polyglutamine protein and promotes their degradation by Proteasomes*. J Biol Chem. 2005;280(12):11635\u201340.","journal-title":"J Biol Chem"},{"issue":"23","key":"1722_CR100","doi-asserted-by":"publisher","first-page":"10424","DOI":"10.1073\/pnas.0914773107","volume":"107","author":"AL Robertson","year":"2010","unstructured":"Robertson AL, et al. Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation. Proc Natl Acad Sci. 2010;107(23):10424\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"1722_CR101","doi-asserted-by":"publisher","first-page":"e4687","DOI":"10.1002\/pro.4687","volume":"32","author":"B Sciandrone","year":"2023","unstructured":"Sciandrone B, et al. HspB8 interacts with BAG3 in a native-like conformation forming a complex that displays chaperone-like activity. Protein Sci. 2023;32(7):e4687.","journal-title":"Protein Sci"},{"issue":"1","key":"1722_CR102","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2990.2011.01198.x","volume":"38","author":"K Seidel","year":"2012","unstructured":"Seidel K, et al. The HSPB8-BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases. Neuropathol Appl Neurobiol. 2012;38(1):39\u201353.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1722_CR103","doi-asserted-by":"crossref","unstructured":"Satyal SH et al. Polyglutamine aggregates alter protein folding homeostasis in <\u2009i\u2009>\u2009Caenorhabditis elegans. Proceedings of the National Academy of Sciences, 2000. 97(11): pp. 5750\u20135755.","DOI":"10.1073\/pnas.100107297"},{"issue":"22","key":"1722_CR104","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1093\/hmg\/ddi372","volume":"14","author":"C Vacher","year":"2005","unstructured":"Vacher C, Garcia-Oroz L, Rubinsztein DC. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington\u2019s disease. Hum Mol Genet. 2005;14(22):3425\u201333.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1722_CR105","doi-asserted-by":"publisher","first-page":"e1003781","DOI":"10.1371\/journal.pgen.1003781","volume":"9","author":"M Cushman-Nick","year":"2013","unstructured":"Cushman-Nick M, Bonini NM, Shorter J. Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD\/SCA3 model. PLoS Genet. 2013;9(9):e1003781.","journal-title":"PLoS Genet"},{"key":"1722_CR106","doi-asserted-by":"publisher","first-page":"e60742","DOI":"10.7554\/eLife.60742","volume":"9","author":"SL Johnson","year":"2020","unstructured":"Johnson SL, et al. Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation. eLife. 2020;9:e60742.","journal-title":"eLife"},{"issue":"3","key":"1722_CR107","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.nbd.2008.10.016","volume":"33","author":"AJ Williams","year":"2009","unstructured":"Williams AJ, et al. In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. Neurobiol Dis. 2009;33(3):342\u201353.","journal-title":"Neurobiol Dis"},{"key":"1722_CR108","doi-asserted-by":"crossref","unstructured":"Baler R, Dahl G, Voellmy R. Activation of human heat shock genes is accompanied by oligomerization, modification, and rapid translocation of heat shock transcription factor HSF1. Molecular and cellular biology; 1993.","DOI":"10.1128\/mcb.13.4.2486-2496.1993"},{"issue":"38","key":"1722_CR109","doi-asserted-by":"publisher","first-page":"26188","DOI":"10.1074\/jbc.M710521200","volume":"283","author":"N Fujikake","year":"2008","unstructured":"Fujikake N, et al. Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones. J Biol Chem. 2008;283(38):26188\u201397.","journal-title":"J Biol Chem"},{"issue":"2","key":"1722_CR110","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","volume":"11","author":"A Silva-Fernandes","year":"2014","unstructured":"Silva-Fernandes A, et al. Chronic treatment with 17-DMAG improves Balance and Coordination in a New Mouse Model of Machado-Joseph Disease. Neurotherapeutics. 2014;11(2):433\u201349.","journal-title":"Neurotherapeutics"},{"issue":"10","key":"1722_CR111","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1021\/cn500075u","volume":"5","author":"C-H Lin","year":"2014","unstructured":"Lin C-H, et al. The potential of indole and a synthetic derivative for polyQ aggregation reduction by enhancement of the chaperone and autophagy systems. ACS Chem Neurosci. 2014;5(10):1063\u201374.","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"1722_CR112","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/hmg\/8.4.673","volume":"8","author":"Y Chai","year":"1999","unstructured":"Chai Y, et al. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3\/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet. 1999;8(4):673\u201382.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1722_CR113","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","volume":"19","author":"HL Paulson","year":"1997","unstructured":"Paulson HL, et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997;19(2):333\u201344.","journal-title":"Neuron"},{"issue":"36","key":"1722_CR114","doi-asserted-by":"publisher","first-page":"32026","DOI":"10.1074\/jbc.M506084200","volume":"280","author":"SJS Berke","year":"2005","unstructured":"Berke SJS, et al. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J Biol Chem. 2005;280(36):32026\u201334.","journal-title":"J Biol Chem"},{"issue":"1","key":"1722_CR115","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1038\/ncomms5638","volume":"5","author":"JR Blount","year":"2014","unstructured":"Blount JR, et al. Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23. Nat Commun. 2014;5(1):4638.","journal-title":"Nat Commun"},{"issue":"2","key":"1722_CR116","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1471-4159.2006.03895.x","volume":"98","author":"LA Khan","year":"2006","unstructured":"Khan LA, et al. Expanded polyglutamines impair synaptic transmission and ubiquitin-proteasome system in Caenorhabditis elegans. J Neurochem. 2006;98(2):576\u201387.","journal-title":"J Neurochem"},{"issue":"6","key":"1722_CR117","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/j.1471-4159.2007.04460.x","volume":"101","author":"H Wang","year":"2007","unstructured":"Wang H, et al. 45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome. J Neurochem. 2007;101(6):1651\u201361.","journal-title":"J Neurochem"},{"issue":"24","key":"1722_CR118","doi-asserted-by":"publisher","first-page":"22044","DOI":"10.1074\/jbc.M212235200","volume":"278","author":"YC Tsai","year":"2003","unstructured":"Tsai YC, et al. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Biol Chem. 2003;278(24):22044\u201355.","journal-title":"J Biol Chem"},{"issue":"1","key":"1722_CR119","doi-asserted-by":"publisher","first-page":"e0147515","DOI":"10.1371\/journal.pone.0147515","volume":"11","author":"W-T He","year":"2016","unstructured":"He W-T, et al. Cytoplasmic ubiquitin-specific protease 19 (USP19) modulates aggregation of polyglutamine-expanded ataxin-3 and huntingtin through the HSP90 chaperone. PLoS ONE. 2016;11(1):e0147515.","journal-title":"PLoS ONE"},{"issue":"01","key":"1722_CR120","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1142\/S0192415X19500046","volume":"47","author":"I-C Chen","year":"2019","unstructured":"Chen I-C, et al. Targeting ubiquitin proteasome pathway with traditional Chinese medicine for treatment of spinocerebellar ataxia type 3. Am J Chin Med. 2019;47(01):63\u201395.","journal-title":"Am J Chin Med"},{"issue":"2","key":"1722_CR121","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0022-510X(97)00151-2","volume":"152","author":"N Giladi","year":"1997","unstructured":"Giladi N. The mechanism of action of Botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci. 1997;152(2):132\u20135.","journal-title":"J Neurol Sci"},{"issue":"2","key":"1722_CR122","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.nurt.2007.01.003","volume":"4","author":"HB Kordasiewicz","year":"2007","unstructured":"Kordasiewicz HB, Gomez CM. Molecular pathogenesis of spinocerebellar ataxia type 6. Neurotherapeutics. 2007;4(2):285\u201394.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"1722_CR123","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cell.2013.05.059","volume":"154","author":"X Du","year":"2013","unstructured":"Du X, et al. Second Cistron in CACNA1A Gene encodes a transcription factor mediating Cerebellar Development and SCA6. Cell. 2013;154(1):118\u201333.","journal-title":"Cell"},{"issue":"347","key":"1722_CR124","doi-asserted-by":"publisher","first-page":"ra34794","DOI":"10.1126\/scitranslmed.aaf5660","volume":"8","author":"Y Miyazaki","year":"2016","unstructured":"Miyazaki Y, et al. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron. Sci Transl Med. 2016;8(347):ra34794\u201334794.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1722_CR125","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12311-018-0917-6","volume":"17","author":"PDH Pastor","year":"2018","unstructured":"Pastor PDH, et al. Targeting the CACNA1A IRES as a treatment for Spinocerebellar Ataxia Type 6. Cerebellum. 2018;17(1):72\u20137.","journal-title":"Cerebellum"},{"issue":"4","key":"1722_CR126","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.neuron.2019.02.036","volume":"102","author":"X Du","year":"2019","unstructured":"Du X, et al. \u03b11ACT is essential for survival and early cerebellar programming in a critical neonatal window. Neuron. 2019;102(4):770\u2013e7857.","journal-title":"Neuron"},{"issue":"7","key":"1722_CR127","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/hmg\/8.7.1185","volume":"8","author":"K Ishikawa","year":"1999","unstructured":"Ishikawa K, et al. Abundant expression and cytoplasmic aggregations of \u03b11A Voltage-Dependent Calcium Channel Protein Associated with Neurodegeneration in Spinocerebellar Ataxia Type 6. Hum Mol Genet. 1999;8(7):1185\u201393.","journal-title":"Hum Mol Genet"},{"key":"1722_CR128","doi-asserted-by":"crossref","unstructured":"Giunti P et al. Molecular mechanism of Spinocerebellar Ataxia type 6: glutamine repeat disorder, channelopathy and transcriptional dysregulation. The multifaceted aspects of a single mutation. Front Cell Neurosci, 2015. 9.","DOI":"10.3389\/fncel.2015.00036"},{"issue":"1","key":"1722_CR129","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00401-023-02680-z","volume":"147","author":"TCS Leung","year":"2024","unstructured":"Leung TCS, et al. Mitochondrial damage and impaired mitophagy contribute to disease progression in SCA6. Acta Neuropathol. 2024;147(1):26.","journal-title":"Acta Neuropathol"},{"issue":"37","key":"1722_CR130","doi-asserted-by":"publisher","first-page":"eabh3260","DOI":"10.1126\/sciadv.abh3260","volume":"8","author":"AA Cook","year":"2022","unstructured":"Cook AA, et al. Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6. Sci Adv. 2022;8(37):eabh3260.","journal-title":"Sci Adv"},{"issue":"11","key":"1722_CR131","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1365-2443.2009.01348.x","volume":"14","author":"L Li","year":"2009","unstructured":"Li L, Saegusa H, Tanabe T. Deficit of heat shock transcription factor 1-heat shock 70\u00a0kDa protein 1A axis determines the cell death vulnerability in a model of spinocerebellar ataxia type 6. Genes Cells. 2009;14(11):1253\u201369.","journal-title":"Genes Cells"},{"issue":"15","key":"1722_CR132","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1093\/hmg\/ddv174","volume":"24","author":"W-L Tsou","year":"2015","unstructured":"Tsou W-L, et al. DnaJ-1 and karyopherin \u03b13 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6. Hum Mol Genet. 2015;24(15):4385\u201396.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"1722_CR133","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1006\/exer.2002.1169","volume":"74","author":"TS Aleman","year":"2002","unstructured":"Aleman TS, et al. Spinocerebellar ataxia type 7 (SCA7) shows a cone\u2013rod dystrophy phenotype. Exp Eye Res. 2002;74(6):737\u201345.","journal-title":"Exp Eye Res"},{"issue":"1","key":"1722_CR134","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.ejhg.5201108","volume":"12","author":"A Michalik","year":"2004","unstructured":"Michalik A, Martin J, Van Broeckhoven C. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy. Eur J Hum Genet. 2004;12(1):2\u201315.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1722_CR135","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ng0997-65","volume":"17","author":"G David","year":"1997","unstructured":"David G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 1997;17(1):65\u201370.","journal-title":"Nat Genet"},{"issue":"2","key":"1722_CR136","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/hmg\/7.2.165","volume":"7","author":"G David","year":"1998","unstructured":"David G, et al. Molecular and clinical correlations in autosomal Dominant Cerebellar Ataxia with Progressive Macular dystrophy (SCA7). Hum Mol Genet. 1998;7(2):165\u201370.","journal-title":"Hum Mol Genet"},{"issue":"465","key":"1722_CR137","doi-asserted-by":"publisher","first-page":"eaap8677","DOI":"10.1126\/scitranslmed.aap8677","volume":"10","author":"C Niu","year":"2018","unstructured":"Niu C, et al. Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7. Sci Transl Med. 2018;10(465):eaap8677.","journal-title":"Sci Transl Med"},{"issue":"8","key":"1722_CR138","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.3390\/ijms25084354","volume":"25","author":"A Niewiadomska-Cimicka","year":"2024","unstructured":"Niewiadomska-Cimicka A, et al. AAV-Mediated CAG-Targeting selectively reduces polyglutamine-expanded protein and attenuates Disease Phenotypes in a Spinocerebellar Ataxia Mouse Model. Int J Mol Sci. 2024;25(8):4354.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1722_CR139","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1371\/journal.pbio.0040067","volume":"4","author":"D Helmlinger","year":"2006","unstructured":"Helmlinger D, et al. Glutamine-expanded ataxin-7 alters TFTC\/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction. PLoS Biol. 2006;4(3):e67.","journal-title":"PLoS Biol"},{"issue":"3","key":"1722_CR140","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.nbd.2005.04.018","volume":"20","author":"A-L Str\u00f6m","year":"2005","unstructured":"Str\u00f6m A-L, Forsgren L, Holmberg M. A role for both wild-type and expanded ataxin-7 in transcriptional regulation. Neurobiol Dis. 2005;20(3):646\u201355.","journal-title":"Neurobiol Dis"},{"issue":"15","key":"1722_CR141","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1101\/gad.300988.117","volume":"31","author":"X Li","year":"2017","unstructured":"Li X, et al. Enzymatic modules of the SAGA chromatin-modifying complex play distinct roles in Drosophila gene expression and development. Genes Dev. 2017;31(15):1588\u2013600.","journal-title":"Genes Dev"},{"issue":"36","key":"1722_CR142","doi-asserted-by":"publisher","first-page":"21996","DOI":"10.1074\/jbc.M114.631663","volume":"290","author":"H Yang","year":"2015","unstructured":"Yang H, et al. Aggregation of polyglutamine-expanded ataxin 7 protein specifically sequesters ubiquitin-specific protease 22 and deteriorates its deubiquitinating function in the Spt-Ada-Gcn5-acetyltransferase (SAGA) complex. J Biol Chem. 2015;290(36):21996\u20132004.","journal-title":"J Biol Chem"},{"issue":"17","key":"1722_CR143","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1093\/hmg\/9.17.2491","volume":"9","author":"G Yvert","year":"2000","unstructured":"Yvert G, et al. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice. Hum Mol Genet. 2000;9(17):2491\u2013506.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1722_CR144","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0896-6273(02)01190-X","volume":"37","author":"S-Y Yoo","year":"2003","unstructured":"Yoo S-Y, et al. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron. 2003;37(3):383\u2013401.","journal-title":"Neuron"},{"issue":"16","key":"1722_CR145","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1093\/hmg\/10.16.1679","volume":"10","author":"G Yvert","year":"2001","unstructured":"Yvert G, et al. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types. Hum Mol Genet. 2001;10(16):1679\u201392.","journal-title":"Hum Mol Genet"},{"issue":"53","key":"1722_CR146","doi-asserted-by":"publisher","first-page":"55969","DOI":"10.1074\/jbc.M409062200","volume":"279","author":"D Helmlinger","year":"2004","unstructured":"Helmlinger D, et al. Hsp70 and Hsp40 chaperones do not modulate retinal phenotype in SCA7 Mice*\u2666. J Biol Chem. 2004;279(53):55969\u201377.","journal-title":"J Biol Chem"},{"issue":"10","key":"1722_CR147","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1523\/JNEUROSCI.5453-06.2007","volume":"27","author":"M Latouche","year":"2007","unstructured":"Latouche M, et al. A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes. J Neurosci. 2007;27(10):2483\u201392.","journal-title":"J Neurosci"},{"issue":"5","key":"1722_CR148","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/hmg\/7.5.913","volume":"7","author":"M Holmberg","year":"1998","unstructured":"Holmberg M, et al. Spinocerebellar Ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet. 1998;7(5):913\u20138.","journal-title":"Hum Mol Genet"},{"issue":"24","key":"1722_CR149","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1093\/hmg\/10.24.2821","volume":"10","author":"A Matilla","year":"2001","unstructured":"Matilla A, et al. Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex. Hum Mol Genet. 2001;10(24):2821\u201331.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1722_CR150","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/hmg\/ddi064","volume":"14","author":"AB Bowman","year":"2005","unstructured":"Bowman AB, et al. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin\u2013proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet. 2005;14(5):679\u201391.","journal-title":"Hum Mol Genet"},{"key":"1722_CR151","doi-asserted-by":"crossref","unstructured":"Marinello M, et al. SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models. Volume 12. Disease models & mechanisms; 2019. p. dmm036145. 1.","DOI":"10.1242\/dmm.036145"},{"issue":"1","key":"1722_CR152","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/hmg\/ddp478","volume":"19","author":"A Janer","year":"2009","unstructured":"Janer A, et al. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7. Hum Mol Genet. 2009;19(1):181\u201395.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1722_CR153","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ana.10676","volume":"54","author":"A Rolfs","year":"2003","unstructured":"Rolfs A, et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol. 2003;54(3):367\u201375.","journal-title":"Ann Neurol"},{"issue":"4","key":"1722_CR154","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.molcel.2012.01.023","volume":"45","author":"A Vannini","year":"2012","unstructured":"Vannini A, Cramer P. Conservation between the RNA polymerase I, II, and III transcription initiation machineries. Mol Cell. 2012;45(4):439\u201346.","journal-title":"Mol Cell"},{"issue":"3","key":"1722_CR155","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrm3952","volume":"16","author":"S Sainsbury","year":"2015","unstructured":"Sainsbury S, Bernecky C, Cramer P. Structural basis of transcription initiation by RNA polymerase II. Nat Rev Mol Cell Biol. 2015;16(3):129\u201343.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"1722_CR156","doi-asserted-by":"publisher","first-page":"8283","DOI":"10.1074\/jbc.M709674200","volume":"283","author":"MJ Friedman","year":"2008","unstructured":"Friedman MJ, et al. Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity. J Biol Chem. 2008;283(13):8283\u201390.","journal-title":"J Biol Chem"},{"issue":"10","key":"1722_CR157","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1212\/01.WNL.0000094123.09098.A0","volume":"61","author":"F Maltecca","year":"2003","unstructured":"Maltecca F, et al. Intergenerational instability and marked anticipation in SCA-17. Neurology. 2003;61(10):1441\u20133.","journal-title":"Neurology"},{"issue":"4","key":"1722_CR158","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s13311-019-00762-z","volume":"16","author":"Q Liu","year":"2019","unstructured":"Liu Q, et al. Molecular mechanisms and therapeutics for SCA17. Neurotherapeutics. 2019;16(4):1097\u2013105.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"1722_CR159","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuron.2013.12.002","volume":"81","author":"S Yang","year":"2014","unstructured":"Yang S, et al. Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice. Neuron. 2014;81(2):349\u201365.","journal-title":"Neuron"},{"issue":"1","key":"1722_CR160","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-018-0236-x","volume":"13","author":"J Guo","year":"2018","unstructured":"Guo J, et al. Piperine ameliorates SCA17 neuropathology by reducing ER stress. Mol Neurodegener. 2018;13(1):4.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"1722_CR161","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cca.2009.12.002","volume":"411","author":"C-M Chen","year":"2010","unstructured":"Chen C-M, et al. SCA17 repeat expansion: mildly expanded CAG\/CAA repeat alleles in neurological disorders and the functional implications. Clin Chim Acta. 2010;411(5):375\u201380.","journal-title":"Clin Chim Acta"},{"issue":"12","key":"1722_CR162","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/nn2011","volume":"10","author":"MJ Friedman","year":"2007","unstructured":"Friedman MJ, et al. Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration. Nat Neurosci. 2007;10(12):1519\u201328.","journal-title":"Nat Neurosci"},{"issue":"12","key":"1722_CR163","doi-asserted-by":"publisher","first-page":"e115809","DOI":"10.1371\/journal.pone.0115809","volume":"9","author":"L-C Lee","year":"2014","unstructured":"Lee L-C, et al. Role of high mobility group box 1 (HMGB1) in SCA17 pathogenesis. PLoS ONE. 2014;9(12):e115809.","journal-title":"PLoS ONE"},{"issue":"7","key":"1722_CR164","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1093\/brain\/awr146","volume":"134","author":"S Huang","year":"2011","unstructured":"Huang S, et al. Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor. Brain. 2011;134(7):1943\u201358.","journal-title":"Brain"},{"key":"1722_CR165","doi-asserted-by":"crossref","unstructured":"Kung P-J et al. Indole and synthetic derivative activate chaperone expression to reduce polyQ aggregation in SCA17 neuronal cell and slice culture models Drug design, development and therapy, 2014: pp. 1929\u20131939.","DOI":"10.2147\/DDDT.S67376"},{"key":"1722_CR166","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.neuro.2018.06.009","volume":"67","author":"C-M Chen","year":"2018","unstructured":"Chen C-M, et al. The indole compound NC009-1 inhibits aggregation and promotes neurite outgrowth through enhancement of HSPB1 in SCA17 cells and ameliorates the behavioral deficits in SCA17 mice. Neurotoxicology. 2018;67:259\u201369.","journal-title":"Neurotoxicology"},{"issue":"3","key":"1722_CR167","doi-asserted-by":"publisher","first-page":"986","DOI":"10.18632\/aging.101804","volume":"11","author":"CM Chen","year":"2019","unstructured":"Chen CM, et al. Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models. Aging. 2019;11(3):986\u20131007.","journal-title":"Aging"},{"key":"1722_CR168","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.brainres.2016.03.004","volume":"1639","author":"Y-C Chang","year":"2016","unstructured":"Chang Y-C, et al. Targeting the prodromal stage of spinocerebellar ataxia type 17 mice: G-CSF in the prevention of motor deficits via upregulating chaperone and autophagy levels. Brain Res. 2016;1639:132\u201348.","journal-title":"Brain Res"},{"issue":"1","key":"1722_CR169","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12192-008-0068-7","volume":"14","author":"HH Kampinga","year":"2009","unstructured":"Kampinga HH, et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2009;14(1):105\u201311.","journal-title":"Cell Stress Chaperones"},{"issue":"38","key":"1722_CR170","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.1002\/anie.201706529","volume":"56","author":"S Tomoshige","year":"2017","unstructured":"Tomoshige S, et al. Discovery of Small molecules that induce the degradation of Huntingtin. Angew Chem Int Ed Engl. 2017;56(38):11530\u20133.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7781","key":"1722_CR171","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","volume":"575","author":"Z Li","year":"2019","unstructured":"Li Z, et al. Allele-selective lowering of mutant HTT protein by HTT\u2013LC3 linker compounds. Nature. 2019;575(7781):203\u20139.","journal-title":"Nature"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-024-01722-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-024-01722-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-024-01722-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T09:20:39Z","timestamp":1732353639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-024-01722-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":171,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1722"],"URL":"https:\/\/doi.org\/10.1007\/s12311-024-01722-w","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"15 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}